These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7915845)

  • 21. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
    Chen P; Zhu H; Ning Y; Yin D; Jia H
    Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early response and 8-week treatment outcome in GAD.
    Rynn M; Khalid-Khan S; Garcia-Espana JF; Etemad B; Rickels K
    Depress Anxiety; 2006; 23(8):461-5. PubMed ID: 16845651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azapirones for generalized anxiety disorder.
    Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Adams JB; Pyke RE; Costa J; Cutler NR; Schweizer E; Wilcox CS; Wisselink PG; Greiner M; Pierce MW; Pande AC
    J Clin Psychopharmacol; 1995 Dec; 15(6):428-34. PubMed ID: 8748432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
    Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states.
    Olajide D; Lader M
    J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Clin Ther; 1997; 19(3):498-506. PubMed ID: 9220214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP; Kieser M
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression.
    Lapierre YD; Silverstone P; Reesal RT; Saxena B; Turner P; Bakish D; Plamondon J; Vincent PM; Remick RA; Kroft C; Payeur R; Rosales D; Lam R; Bologa M
    J Clin Psychopharmacol; 1998 Aug; 18(4):268-73. PubMed ID: 9690691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: Results of a multicenter randomized comparative study of diazepam].
    Syunyakov TS; Neznamov GG
    Ter Arkh; 2016; 88(8):73-86. PubMed ID: 27636931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.